"Les yeux sont aveugles. Il faut chercher avec le coeur." Antoine de Saint Exupéry
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.046941 CIRCULATION 23 03 2020
Conclusion
COVID-19, caused by SARS-CoV-2, is a global pandemic evolving in real time. Cardiovascular comorbidities are common in patients with COVID-19 and such patients are at higher risk of morbidity and mortality. However, it is not known if the presence of cardiovascular comorbid
conditions pose independent risk or whether this is mediated by other factors (e.g. age). myocardial injury is present in more than a quarter of critical cases and presents in two patterns: acute myocardial injury and dysfunction on presentation and myocardial injury that develops as illness severity intensifies. The continuation of clinically indicated ACEi and ARB medications is recommended based on the available evidence at this time.There are a number of promising treatments under investigation,but none with proven clinical efficacy to date.
D'autres articles sur le même sujet vont être publiés, le facteur de risque cardio vasculaire existe et c'est normal, mais c'est l'association de plusieurs facteurs de co morbidité qui fait le pronostic.
